Evaluation of frequency and the attacks features of patients with colchicine resistance in FMF

Cetin G. Y., Balkarli A., Oksuz A. N., Kimyon G., Pehlivan Y., Orhan O., ...More

REVISTA BRASILEIRA DE REUMATOLOGIA, vol.54, no.5, pp.356-359, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 54 Issue: 5
  • Publication Date: 2014
  • Doi Number: 10.1016/j.rbr.2014.03.022
  • Journal Name: REVISTA BRASILEIRA DE REUMATOLOGIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.356-359
  • Bursa Uludag University Affiliated: Yes

Abstract

Introduction: Colchicine is the mainstay for the treatment of FMF, which is an auto- inflammatory disease mainly with relapsing polyserositis. Despite daily doses of 2 mg or more each day, approximately 5% to 10% of the patients continue to suffer from its attacks. In this study, we aimed to investigate the depression and attack features in patients with FMF who have colchicine resistance (CR).